
Journal of Medicinal Chemistry p. 816 - 819 (1986)
Update date:2022-08-02
Topics:
Press, Jeffery B.
Wright, William B.
Chan, Peter S.
Marsico, Joseph W.
Haug, Margie F.
et al.
A series of N-<(1H-heteroaryl)alkyl>-1H-isoindole-1,3(2H)-diones were prepared as part of a continuing investigation into the biological properties of compounds that were both thromboxane synthetase inhibitors and potential antihypertensive agents.The most active thromboxane synthetase inhibition was found for the title imidazole derivatives wherein a hexyl or octyl chain separated the heterocyclic ends of the molecule (5,6) or with substitution on the isoindole portion of the molecule (18, 19, 21, 22, 25, 26).Compounds with shorter alkyl chain separations had good ant ihypertensive effects (1-5, 8-10, 19-22, 27-30).Butyl derivative 3 was chosen for further evaluation as a potential antihypertensive agent with thromboxane synthetase inhibitory properties.
View MoreShenzhen HwaGen Pharmaceutical Co., Ltd
website:http://www.rafflespt.com
Contact:+86-752-5538396
Address:Guangdong Huizhou China
Anhui Biochem United Pharmaceutical Co., Ltd.
Contact:0086 551 5167062 / 5228268
Address:No. 30 Hongfeng Road, Hi-Tech Development Zone, Hefei (230088), China
Rudong Zhenfeng Yiyang Chemical Co., Ltd.
Contact:0513-84573047
Address:South Fengli Town, Rudong County, Jiangsu Province, China
Shanghai Sunway Pharmaceutical Technology Co.,Ltd.
Contact:+86-21-5161 3915
Address:Shanghai YangPu
chengdu firsterchem Pharmaceutical Co., Ltd.
Contact:028-66825849
Address:chengdu
Doi:10.1021/ja0686763
(2007)Doi:10.1135/cccc19841699
(1984)Doi:10.1021/jo0701942
(2007)Doi:10.1016/j.ica.2006.10.021
(2007)Doi:10.1039/c9cc04141a
(2019)Doi:10.1039/c39840000837
(1984)